|1.||Andrews, Robert K: 5 articles (03/2009 - 12/2004)|
|2.||Watson, S P: 4 articles (08/2015 - 07/2001)|
|3.||Andrews, R K: 4 articles (08/2015 - 07/2001)|
|4.||Gardiner, E E: 4 articles (08/2015 - 07/2001)|
|5.||Arthur, Jane F: 4 articles (03/2009 - 12/2004)|
|6.||Gardiner, Elizabeth E: 4 articles (03/2009 - 12/2004)|
|7.||Berndt, M C: 3 articles (08/2009 - 07/2001)|
|8.||Berndt, Michael C: 3 articles (03/2009 - 12/2004)|
|9.||Gawaz, Meinrad: 3 articles (07/2008 - 03/2007)|
|10.||Heemskerk, Johan W M: 2 articles (01/2014 - 07/2010)|
|1.||Atherosclerotic Plaque (Atheroma)
07/01/2008 - "In the present study we studied the binding of the platelet collagen receptor glycoprotein (GP) VI to human atherosclerotic plaques (AP) and the role of GPVI-mediated platelet adhesion for atheroprogression. "
05/01/2007 - "Thrombus formation after atherosclerotic plaque rupture critically involves the platelet collagen receptor glycoprotein (GP) VI. We investigated the impact of EXP3179, an active metabolite of the angiotensin II type 1 (AT1)-receptor antagonist Losartan (LOS) on GPVI-dependent platelet activation. "
01/01/2007 - "Recent progress in the understanding of thrombus formation has suggested an important role for glycoprotein (GP) VI in this process. "
01/01/2014 - "Three types of thrombus formation can be identified with a predicted hierarchy of the following receptors: glycoprotein (GP)VI, C-type lectin-like receptor-2 (CLEC-2)>GPIb>α6β1, αIIbβ3>α2β1>CD36, α5β1, αvβ3. "
02/01/2012 - "Collagen-induced platelet activation is a key step in the development of arterial thrombosis via its interaction with the receptors glycoprotein (GP)VI and integrin α(2) β(1) . "
07/30/2010 - "Upon high shear flow of blood over collagen, Stim1(-/-) and Orai1(-/-) platelets had greatly impaired glycoprotein (GP) VI-dependent Ca(2+) signals, and they were deficient in PS exposure and thrombus formation. "
03/01/2009 - "The platelet collagen receptor, glycoprotein (GP) VI, is critical for thrombus formation at arterial shear rates and is a potential therapeutic target for anti-thrombotic drugs. "
08/01/2009 - "Glycoprotein (GP)VI deficiency is a rare platelet disorder with a mild bleeding tendency. "
11/01/2007 - "Human patients with defects associated with the platelet collagen receptor, glycoprotein (GP)VI, are rare and usually described as having a mild bleeding disorder. "
08/01/2006 - "Recent progress in the understanding of thrombus formation has suggested an important role of glycoprotein (GP)VI. In contrast to its pivotal role in collagen-induced platelet activation, it has been suggested that its blockade does not induce massive bleeding tendency. "
08/01/2015 - "Here, we characterised an atypical immunoglobulin (Ig)M PCA in a 37-year-old woman with lifelong bleeding and chronic moderate thrombocytopenia, that induces activation and aggregation of autologous or allogeneic platelets via interaction with platelet glycoprotein (GP)VI. Patient temperature-dependent pseudothrombocytopenia was EDTA-independent, but was prevented by integrin αIIbβ3 blockade. "
09/01/2013 - "In contrast, deficiency in the immunoreceptor tyrosine-based activation motif (ITAM)-coupled receptors glycoprotein (GP)VI or C-type lectin-like receptor (CLEC)-2 is associated with only a mild bleeding diathesis in humans and mice. "
|5.||Gray Platelet Syndrome
|3.||von Willebrand Factor
|4.||C-Type Lectins (C-Type Lectin)
|5.||von Willebrand factor receptor (VWF receptor)
|6.||CD147 Antigens (Basigin)
|7.||Matrix Metalloproteinase 9 (Gelatinase B)